부산대학교 도서관

Lee NR; Department of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ, USA.; King A; College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.; Vigil D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Mullaney D; Department of Biology, Northern Arizona University, Flagstaff, AZ, USA.; Sanderson PR; Department of Health Sciences, College of Health and Human Services, Northern Arizona University, Flagstaff, AZ, USA.; Ametepee T; College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.; Hammitt LL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: lhammitt@jhu.edu.

Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

Huaman MA; Department of Internal Medicine, Division of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, USA.; Raval JS; Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.; Paxton JH; Department of Emergency Medicine, Wayne State University, Detroit, Michigan, USA.; Mosnaim GS; Department of Medicine, Division of Allergy and Immunology, NorthShore University Health System, Evanston, Illinois, USA.; Patel B; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, Texas, USA.; Anjan S; Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.; Meisenberg BR; Luminis Health, Annapolis, Maryland, USA.; Levine AC; Department of Emergency Medicine, Rhode Island Hospital & Brown University, Providence, Rhode Island, USA.; Marshall CE; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Yarava A; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Shenoy AG; Department of Medicine, Division of Hematology and Oncology, MedStar Washington Hospital Center, DC, USA.; Heath SL; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Currier JS; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, USA.; Fukuta Y; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.; Blair JE; Department of Medicine, Division of Infectious Diseases, Mayo Clinic Hospital, Phoenix, Arizona, USA.; Spivak ES; Department of Medicine, Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Petrini JR; Nuvance Health, Danbury, Connecticut, USA.; Broderick PB; Nuvance Health Danbury Hospital, Danbury, Connecticut, USA.; Rausch W; Nuvance Health, Danbury, Connecticut, USA.; Cordisco M; Nuvance Health, Danbury, Connecticut, USA.; Hammel J; Nuvance Health Norwalk Hospital, Norwalk, Connecticut, USA.; Greenblatt B; Nuvance Health Norwalk Hospital, Norwalk, Connecticut, USA.; Cluzet VC; Nuvance Health Vassar Brothers Medical Center, Poughkeepsie, New York, USA.; Cruser D; Nuvance Health Vassar Brothers Medical Center, Poughkeepsie, New York, USA.; Oei K; Ascada Research, Fullerton, California, USA.; Abinante M; Ascada Research, Fullerton, California, USA.; Hammitt LL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Sutcliffe CG; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Forthal DN; Department of Medicine, Division of Infectious Diseases, University of California, Irvine, California, USA.; Zand MS; Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.; Cachay ER; Department of Medicine, Division of Infectious Diseases, University of California, San Diego, California, USA.; Kassaye SG; Department of Medicine, Division of Infectious Diseases, Georgetown University Medical Center, DC, USA.; Ram M; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Wang Y; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Das P; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Lane K; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; McBee NA; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Gawad AL; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Karlen N; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Ford DE; Institute for Clinical and Translational Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Laeyendecker O; The Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.; Pekosz A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Klein SL; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Ehrhardt S; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Lau B; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Baksh SN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Shade DM; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Hanley DF; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Ou J; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Gniadek TJ; Department of Pathology and Laboratory Medicine, NorthShore University Health System, Evanston, Illinois, USA.; Ziman A; Department of Pathology and Laboratory Medicine, Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, David Geffen School of Medicine, University of California, Los Angeles, California, USA.; Shoham S; Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Gebo KA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Bloch EM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Tobian AAR; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Sullivan DJ; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Gerber JM; Department of Medicine, Division of Hematology and Oncology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE

Zhu X; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Gebo KA; Department of Medicine, Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Abraham AG; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Department of Epidemiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; Habtehyimer F; Department of Medicine, Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Patel EU; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.; Laeyendecker O; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Washington, DC, USA.; Gniadek TJ; Department of Pathology and Laboratory Medicine, Northshore University Health System, Evanston, IL, USA.; Fernandez RE; Department of Medicine, Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Baker OR; Department of Medicine, Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Ram M; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.; Cachay ER; Department of Medicine, Division of Infectious Diseases, University of California, San Diego, San Diego, CA, USA.; Currier JS; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, CA, USA.; Fukuta Y; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA.; Gerber JM; Department of Medicine, Division of Hematology and Oncology, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Heath SL; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.; Meisenberg B; Department of Medicine and Research Institute of Luminis Health, Annapolis, MD, USA.; Huaman MA; Department of Medicine, Division of Infectious Diseases University of Cincinnati, Cincinnati, OH, USA.; Levine AC; Department of Emergency Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.; Shenoy A; Division of Hematology, Medstar DC Hospital, Washington, DC, USA.; Anjan S; Department of Medicine, Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL, USA.; Blair JE; Department of Medicine, Division of Infectious Diseases, Mayo Clinic Hospital, Phoenix, AZ, USA.; Cruser D; Department of Pathology, Nuvance Health Vassar Brothers Medical Center, Poughkeepsie, NY, USA.; Forthal DN; Department of Medicine, Division of Infectious Diseases, University of California, Irvine, CA, USA.; Hammitt LL; Department of International Health, Johns Hopkins University, Baltimore, MD, USA.; Kassaye S; Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC, USA.; Mosnaim GS; Division of Allergy and Immunology, Department of Medicine, Northshore University Health System, Evanston, IL, USA.; Patel B; Department of Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, TX, USA.; Paxton JH; Department of Emergency Medicine, Wayne State University, Detroit, MI, USA.; Raval JS; Department of Pathology, University of New Mexico, Albuquerque, NM, USA.; Sutcliffe CG; Department of International Health, Johns Hopkins University, Baltimore, MD, USA.; Abinante M; Ascada Research, Los Angeles, CA, USA.; Broderick P; Department of Emergency Medicine, Nuvance Health Danbury Hospital, Danbury, CT, USA.; Cluzet V; Department of Infectious Disease, Nuvance Health Vassar Brothers Medical Center, Poughkeepsie, NY, USA.; Cordisco ME; Department of Emergency Medicine, Nuvance Health Danbury Hospital, Danbury, CT, USA.; Greenblatt B; Department of Emergency Medicine, Nuvance Health Norwalk Hospital, Norwark, CT, USA.; Petrini J; Department of Emergency Medicine, Nuvance Health Danbury Hospital, Danbury, CT, USA.; Rausch W; Department of Emergency Medicine, Nuvance Health Danbury Hospital, Danbury, CT, USA.; Shade D; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.; Lane K; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Gawad AL; Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.; Klein SL; Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.; Pekosz A; Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.; Shoham S; Department of Medicine, Division of Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.; Bloch EM; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Hanley D; Department of Neurology, Brain Injury Outcomes Division, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Sullivan DJ; Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.; Tobian AAR; Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: atobian1@jhmi.edu.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

Atwell JE; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Hartman RM; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Parker D; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Taylor K; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Brown LB; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Sandoval M; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Ritchie N; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Desnoyers C; Yukon-Kuskokwim Health Corporation, Bethel, Alaska.; Wilson AS; Alaska Native Tribal Health Consortium, Anchorage, Alaska.; Hammes M; Southcentral Foundation, Anchorage, Alaska.; Tiesinga J; Alaska Native Tribal Health Consortium, Anchorage, Alaska.; Halasa N; Vanderbilt University Medical Center, Nashville, Tennessee.; Langley G; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.; Prill MM; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.; Bruden D; Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.; Close R; Indian Health Service, Whiteriver Service Unit, Whiteriver, Arizona.; Moses J; Indian Health Service, Chinle Service Unit, Chinle, Arizona.; Karron RA; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Santosham M; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Singleton RJ; Alaska Native Tribal Health Consortium, Anchorage, Alaska.; Hammitt LL; Center for Indigenous Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Publisher: American Academy of Pediatrics Country of Publication: United States NLM ID: 0376422 Publication Model: Print Cited Medium: Internet ISSN: 1098-4275 (Electronic) Linking ISSN: 00314005 NLM ISO Abbreviation: Pediatrics Subsets: MEDLINE

Muller WJ; Northwestern University, Chicago, IL.; Madhi SA; University of the Witwatersrand, Johannesburg, South Africa.; Seoane Nuñez B; AstraZeneca, Barcelona, Spain.; Baca Cots M; Quirónsalud Málaga Hospital, Malaga, Spain.; Bosheva M; St. George Medical University, Plovdiv, Bulgaria.; Dagan R; Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Hammitt LL; Johns Hopkins University, Baltimore, MD.; Llapur CJ; Hospital del Niño Jesús, San Miguel de Tucumán, Argentina.; Novoa JM; Hospital Padre Hurtado, Santiago, Chile.; Saez Llorens X; Cevaxin Research Center, Panama City, Panama.; Grenham A; AstraZeneca, Gaithersburg, MD.; Kelly EJ; AstraZeneca, Gaithersburg, MD.; Mankad VS; AstraZeneca, Durham, NC.; Shroff M; AstraZeneca, Waltham, MA.; Takas T; AstraZeneca, Gaithersburg, MD tonya.villafana@astrazeneca.com.; Leach A; AstraZeneca, Gaithersburg, MD tonya.villafana@astrazeneca.com.; Villafana T; AstraZeneca, Gaithersburg, MD tonya.villafana@astrazeneca.com.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Lutz CS; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Hartman RM; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Vigil DE; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Britton A; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Burrage AB; Tuba City Service Unit, Navajo Area, Indian Health Service, Tuba City, Arizona, USA.; Campbell AP; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Close RM; Whiteriver Service Unit, Phoenix Area, Indian Health Service, Whiteriver, Arizona, USA.; Desnoyers C; Yukon-Kuskokwim Health Corporation, Bethel, Alaska, USA.; Dobson J; Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA.; Garcia S; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Halasa N; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Honie E; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Kobayashi M; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; McMorrow M; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Mostafa HH; Division of Medical Microbiology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Parker D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Pohl K; Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA.; Prill MM; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Richards J; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Roessler KC; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Sutcliffe CG; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Taylor K; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Swango-Wilson A; Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA.; Va P; Chinle Service Unit, Navajo Area, Indian Health Service, Chinle, Arizona, USA.; Verani JR; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Singleton RJ; Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA.; Hammitt LL; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

Gebo KA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Heath SL; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL.; Fukuta Y; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX.; Zhu X; Department of Pathology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Baksh S; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Abraham AG; Department of Epidemiology, University of Colorado, Anschutz Medical Campus, Aurora CO.; Habtehyimer F; Department of Medicine, Division of Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Shade D; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Ruff J; Department of Pathology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Ram M; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Laeyendecker O; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH.; Fernandez RE; Department of Medicine, Division of Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Patel EU; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Baker OR; Department of Medicine, Division of Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Shoham S; Department of Medicine, Division of Infectious Diseases, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Cachay ER; Department of Medicine, Division of Infectious Diseases, University of California, San Diego, San Diego, CA.; Currier JS; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA.; Gerber JM; Department of Medicine, Division of Hematology and Oncology, University of Massachusetts, Worchester, MA.; Meisenberg B; Luminis Health, Annapolis, MD.; Forthal DN; Department of Medicine, Division of Infectious Diseases, University of California, Irvine, Irvine, CA.; Hammitt LL; International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Huaman MA; Department of Medicine, Division of Infectious Diseases University of Cincinnati, Cincinnati, OH.; Levine A; Department of Emergency Medicine, Rhode Island Hospital Warren Alpert Medical School of Brown University, Providence, RI.; Mosnaim GS; Division of Allergy and Immunology, Department of Medicine, Northshore University Health System, Evanston, IL.; Patel B; Department of Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, TX.; Paxton JH; Department of Emergency Medicine, Wayne State University, Detroit, MI.; Raval JS; Department of Pathology, University of New Mexico, Albuquerque, NM.; Sutcliffe CG; International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Anjan S; Department of Medicine, Department of Medicine, Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL.; Gniadek T; Department of Pathology, Northshore University Health System, Evanston, IL.; Kassaye S; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Blair JE; Department of Medicine, Division of Infectious Diseases, Mayo Clinic Hospital, Phoenix, AZ.; Lane K; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; McBee NA; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Gawad AL; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Das P; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Klein SL; Division of Infectious Diseases, Medstar Georgetown University Hospital, Washington, D.C.; Pekosz A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Bloch EM; Department of Pathology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Hanley D; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Tobian AAR; Department of Pathology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.; Sullivan DJ; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Close RM; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Sutcliffe CG; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: csutcli1@jhu.edu.; Galdun P; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Reid A; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Askew MR; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Davidson AM; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Kellywood K; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Parker D; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Patel J; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Romancito E; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Brown LB; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; McAuley JB; Whiteriver Service Unit, Indian Health Service, Whiteriver, AZ, USA.; Hammitt LL; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn Microbiol Infect Dis Subsets: MEDLINE

Ji N; Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ, USA.; Rule AM; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Weatherholtz R; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. rweathe1@jhu.edu.; Crosby L; United States Geological Survey, Reston, VA, USA.; Bunnell JE; United States Geological Survey, Reston, VA, USA.; Orem B; United States Geological Survey, Reston, VA, USA.; Reid R; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Santosham M; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Hammitt LL; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; O'Brien KL; Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101262796 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-064X (Electronic) Linking ISSN: 15590631 NLM ISO Abbreviation: J Expo Sci Environ Epidemiol Subsets: MEDLINE

Moreira ED Jr; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Kitchin N; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Xu X; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Dychter SS; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Lockhart S; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Gurtman A; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Perez JL; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Zerbini C; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Dever ME; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Jennings TW; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Brandon DM; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Cannon KD; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Koren MJ; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Denham DS; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Berhe M; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Fitz-Patrick D; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Hammitt LL; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Klein NP; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Nell H; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Keep G; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Wang X; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Koury K; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Swanson KA; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Cooper D; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Lu C; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Türeci Ö; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Lagkadinou E; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Tresnan DB; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Dormitzer PR; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Şahin U; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Gruber WC; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).; Jansen KU; From Associação Obras Sociais Irmã Dulce and the Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) - both in Brazil; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., G.K.); Vaccine Research and Development, Pfizer, Collegeville, PA (X.X., J.L.P., X.W.); Vaccine Research and Development, Pfizer (S.S.D.), and California Research Foundation (D.M.B.), San Diego, and Kaiser Permanente Vaccine Study Center, Oakland (N.P.K.) - all in California; Vaccine Research and Development, Pfizer, Pearl River, NY (A.G., K.K., K.A.S., D.C., C.L., P.R.D., W.C.G., K.U.J.); Clinical Neuroscience Solutions, Orlando (M.E.D.), and Jacksonville Center for Clinical Research, Jacksonville (M.J.K.) - both in Florida; Clinical Research Professionals, Chesterfield, MO (T.W.J.); Accellacare, Wilmington, NC (K.D.C.); Clinical Trials of Texas, San Antonio (D.S.D.), and North Texas Infectious Diseases Consultants, Dallas (M.B.); East-West Medical Research Institute, Honolulu (D.F.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); Tiervlei Trial Centre, Karl Bremer Hospital, Cape Town, South Africa (H.N.); BioNTech, Mainz, Germany (Ö.T., E.L., U.Ş.); and Worldwide Safety, Safety Surveillance and Risk Management, Pfizer, Groton, CT (D.B.T.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE